Evidence map›Paper›PMID 42099390›Full record

ArticleFrontiers in cell and developmental biology2026

Altered brain vascularization and transcriptional changes in embryos lacking ABCA1 support a role of cholesterol in brain angiogenesis.

Brenda Becerra, Oriana Ramírez-Herrera, Javiera Barrios, Josefina Madrid, Susan Calfunao, Fujiko Saavedra, Patricia Romo-Toledo, Jesús Juárez-Balarezo, Ignacio Casanova-Maldonado, Thomas Arnold and 3 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Brenda BecerraInstituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.
Oriana Ramírez-HerreraInstituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.
Javiera BarriosInstituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.
Josefina MadridInstituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.
Susan CalfunaoInstituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.
Fujiko SaavedraCentro de Investigación e Innovación Biomédica, Universidad de los Andes, Santiago, Chile.
Patricia Romo-ToledoCentro de Investigación e Innovación Biomédica, Universidad de los Andes, Santiago, Chile.
Jesús Juárez-BalarezoLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences, Universidad de Chile, Santiago, Chile.
Ignacio Casanova-MaldonadoLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences, Universidad de Chile, Santiago, Chile.
Thomas ArnoldDepartment of Pediatrics, University of California, San Francisco, CA, United States.
Verónica PalmaLaboratory of Stem Cells and Developmental Biology, Faculty of Sciences, Universidad de Chile, Santiago, Chile.
Dolores BussoCentro de Investigación e Innovación Biomédica, Universidad de los Andes, Santiago, Chile.
Nicolas SantanderInstituto de Ciencias de la Salud, Universidad de O´Higgins, Rancagua, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lipoproteins are the main lipid carriers in extracellular fluids and mediate the exchange of hydrophobic molecules between cells and their environment in animals, including cholesterol. Lipoprotein metabolism has been implicated in the regulation of angiogenesis, suggesting that cholesterol is important for this process, but a direct role for this lipid has not been unequivocally demonstrated, particularly in the central nervous system (CNS). Methods: Here, we used genetic and pharmacological models to address this issue in different models of CNS angiogenesis. Results: We show that inactivation of ABCA1, one of the main cholesterol efflux pumps, leads to altered brain vascularization and a longer angiogenic window, while inactivation of the bidirectional cholesterol transporter SR-B1 has no effect. These functional changes are accompanied by consistent transcriptomic changes in genes involved in cholesterol synthesis and angiogenesis. In support of the role of cholesterol, experimental reduction of this lipid in cultured brain endothelial cells leads to a transcriptomic signature showing the opposite direction in those genes. Discussion: These studies support a role for ABCA1 and cholesterol in regulating a trascriptional program governing angiogenesis in the brain.

Indexed as

ABCA1angiogenesisblood-brain barrierbraincholesterol

Identifiers

PMID42099390
PMCPMC13143920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.